IVF/ICSI in a woman with active acromegaly: successful outcome following treatment with pegvisomant

J Assist Reprod Genet. 2006 Nov-Dec;23(11-12):439-42. doi: 10.1007/s10815-006-9077-6. Epub 2006 Nov 28.

Abstract

A 29 year old woman with difficult to control acromegaly and a pituitary macroadenoma responded to pegvisomant therapy and subsequently conceived with her first cycle of in-vitro fertilization and intra-cytoplasmic sperm injection. Pregnancy was complicated by gestational diabetes, pituitary gland enlargement and deteriorating visual fields. Conservative management with elective cesarean section was performed at 32 weeks gestation. A healthy boy was delivered who remains developmentally normal at 1 year. This complex case required intricate care by a multi-disciplinary team and is likely to represent the first in many cases of assisted conception on pegvisomant therapy for active acromegaly.

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / radiotherapy
  • Acromegaly / surgery
  • Adult
  • Female
  • Fertilization in Vitro*
  • Human Growth Hormone / analogs & derivatives*
  • Human Growth Hormone / therapeutic use
  • Humans
  • Hypophysectomy
  • Magnetic Resonance Imaging
  • Pituitary Gland / pathology
  • Sperm Injections, Intracytoplasmic*

Substances

  • Human Growth Hormone
  • pegvisomant